Seeking Alpha

More on Allscripts (MDRX): Q4 misses on all counts as results were hit by weaker sales, a...

More on Allscripts (MDRX): Q4 misses on all counts as results were hit by weaker sales, a deferred-revenue provision plus other items. Total revenue declined 9.6% Y/Y and gross margin fell to 38.8% from 45.1%. One bright spot however, was bookings - a key leading indicator for health IT firms - which came in at $180.7M, well ahead of consensus expectations. That is driving the stock higher in the post-trading session, with shares currently +6.4%.

Check out Seeking Alpha’s new Earnings Center »

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs